Impact of tuberculosis disease on human gut microbiota: a systematic review
Tejaswini Baral, Shilia Jacob Kurian, Levin Thomas, Chandrashekar Udyavara Kudru, Chiranjay Mukhopadhyay, Kavitha Saravu, Mohan K Manu, Jitendra Singh, Murali Munisamy, Amit Kumar, Bidita Khandelwal, Mahadev Rao, Sonal Sekhar Miraj
Abstract
INTRODUCTION: This systematic review evaluates the gut microbiota (GM) status in tuberculosis (TB) patients compared to healthy volunteers due to the disease or its treatment. AREAS COVERED: disease. EXPERT OPINION: The modulation of GM in TB patients in clinical practice may serve as a promising target to reverse the dysbiosis caused. Moreover, this can optimistically change the TB treatment outcome. We expect that appropriate probiotic supplementation with antimycobacterial treatment during tuberculosis disease will help stabilize the GM throughout the treatment phase and protect the GM from dysbiosis.